Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Originally published as JCO Early Release 10.1200/JCO.2008.19.5883 on November 3 2008

Journal of Clinical Oncology, Vol 26, No 34 (December 1), 2008: pp. 5654-5655
© 2008 American Society of Clinical Oncology.

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vergote, I.
Right arrow Articles by Van Limbergen, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vergote, I.
Right arrow Articles by Van Limbergen, E.
Related Articles
Right arrowRelated Reply
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

CORRESPONDENCE

Value of Positron Emission Tomography of the Para-Aortic Lymph Nodes in Cervical Carcinoma Stage IB2-IIIB

Ignace Vergote, Dimitris Tsolakidis, Dieter Mortier, Patrick Neven, Frederic Amant

Department of Obstetrics and Gynaecology, University Hospitals Leuven, Belgium

Felix Mottaghy

Department of Nuclear Medicine, University Hospitals Leuven, Belgium

Erik Van Limbergen

Department of Radiotherapy, University Hospitals Leuven, Belgium

To the Editor:

We read with interest the article by Boughanim et al1 on the value of positron emission tomography combined with computed tomography (PET-CT) scans in the para-aortic (PAO) area in patients with stage IB2-II cervical cancer. However, this study was hampered by an important delay between the PET-CT and the PAO lymphadenectomy (median, 123 days; range, 31 to 196 days), which makes interpretation of the value of PET-CT in detecting PAO lymph node metastases difficult.

The authors analyzed 38 patients and observed that 8% of their patients (three patients) had histologically proven PAO involvement, despite a negative PET-CT in the PAO area. Furthermore, the authors suggest these metastatic PAO lymph nodes are usually large and have capsular rupture. Finally, they suggest treating patients with negative PET scan but metastatic PAO lymph nodes with PAO radiotherapy.

We question the statements of the authors that the PAO nodes are usually large and have capsular growth, and that the para-aortic area should be treated with PAO radiotherapy only. In our study of 44 cervical carcinoma patients (stage IB2-IIIB) without PAO metastases on PET and CT scans or PET-CT, a laparoscopic PAO lymphadenectomy was performed immediately (within 1 week) after the PET scan.2 In five (11%) of our patients, metastatic PAO nodes were observed.

For this letter, we updated our series and have currently performed 85 laparoscopic PAO lymphadenectomies after negative PET and CT scans or negative PET-CT, and observed nine patients with metastases in the para-aortic nodes (11%). The characteristics of the patients with metastatic PAO lymph nodes are summarized in Table 1. All metastatic lymph nodes were smaller than 1 cm, and none had capsular rupture. The laparoscopic procedure was stopped once a PAO metastasis was found on frozen section. All patients underwent pelvic and PAO radiochemotherapy in case of PAO lymph node metastasis. Patient 9 was treated with neoadjuvant chemotherapy followed by radiochemotherapy to the pelvic and PAO area.


View this table:
[in this window]
[in a new window]

 
Table 1. Characteristics of Nine Cervical Carcinoma Patients (Stage IB2-IIIB) With Metastatic PAO Lymph Nodes at Laparoscopy and Negative PET Scan and CT Scan or Negative PET-CT in the PAO Area

 
We hypothesize that the PET scans were negative in our series because of the limited spatial resolution of PET in small lesions and not because of a different metabolic rate. The larger size and capsular rupture observed by Boughanim et al1 might be due to the long delay between the PET scan and the lymphadenectomy. It would be interesting to know the delay in their patients with PAO lymph node metastases.

Furthermore, in our experience, patients with PAO lymph node metastases and negative PET scan have a poor prognosis, even when treated with PAO radiochemotherapy (Table 1). In addition, in our series, these patients often experienced recurrence outside the pelvic and PAO area. Hence, we suggest that other treatment strategies such as (neoadjuvant) chemotherapy or molecular targeted therapy should be evaluated in this group of patients.

AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

The author(s) indicated no potential conflicts of interest.

NOTES

published online ahead of print at www.jco.org on November 3, 2008

REFERENCES

1. Boughanim M, Leboulleux S, Rey A, et al: Histologic results of PAO lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F] fluorodeoxyglucose positron emission tomography scans in the para-aortic area. J Clin Oncol 15:2558-2561, 2008

2. Mortier DG, Stroobants S, Amant F, et al: Laparoscopic para-aortic lymphadenectomy and positron emission tomography scan as staging procedures in patients with cervical carcinoma stage IB2-IIIB. Int J Gynecol Cancer 2008 18:723-729, 2008


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Reply

  • In Reply
    Philippe Morice, Enrica Bentivegna, Catherine Uzan, Sebastien Gouy, Martin Schlumberger, Pierre Duvillard, and Christine Haie-Meder
    JCO 2008 26: 5655-5657 [Full Text]

Related Article

  • Histologic Results of Para-Aortic Lymphadenectomy in Patients Treated for Stage IB2/II Cervical Cancer With Negative [18F]Fluorodeoxyglucose Positron Emission Tomography Scans in the Para-Aortic Area
    Mathias Boughanim, Sophie Leboulleux, Annie Rey, Chi Tuan Pham, Yaelle Zafrani, Pierre Duvillard, Jean Lumbroso, Christine Haie-Meder, Martin Schlumberger, and Philippe Morice
    JCO 2008 26: 2558-2561 [Abstract] [Full Text]



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vergote, I.
Right arrow Articles by Van Limbergen, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vergote, I.
Right arrow Articles by Van Limbergen, E.
Related Articles
Right arrowRelated Reply
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online